01 — At a Glance
The Specialty Chemicals Company That Bets It All on Batteries
- 52-Week High / Low₹4,098 / ₹2,917
- FY26 TTM Revenue₹4,852 Cr
- FY26 TTM PAT₹656 Cr
- TTM EPS₹59.72
- Current P/E51.9x
- Book Value₹693
- Price to Book4.54x
- Dividend Yield0.09%
- Debt / Equity0.23x
- ROCE9.89%
The Paradox: GFL’s TTM ROCE is just 9.89% — half the fluoropolymer industry baseline. Its P/E is 51.9x while peers trade at 26.1x median. And yet the company is commissioning three battery material plants, secured ₹430 crore from IFC, and signed sovereign funds for a $82 million Oman capex. Either the market is pricing in 300%+ growth over five years, or it’s pricing in hope.
02 — Introduction
Specialty Chemicals Meets EV Fever. What Could Go Wrong?
Gujarat Fluorochemicals Ltd is a ₹34,626 crore market-cap behemoth that makes fluoropolymers, refrigerants, and specialty chemicals. Think PTFE, PFA, refrigerant gases, caustic soda, and chloroform. Boring? Monumentally. Profitable? Usually. But since late 2024, the company has pivoted hard into battery materials — lithium-ion fluorophosphate (LiPF6), cathode active materials (CAM), binders, and electrolytes. It’s the industrial equivalent of a balding uncle suddenly buying a sports car.
The company has been around for 90+ years (part of the INOX Group), operates manufacturing plants in Dahej, Ranjitnagar, and Morocco, and exports to 60+ countries. Until recently, it was a steady earner: 30% operating margins, predictable cash flows, and zero drama. Then, in late 2024, it repositioned itself as an alternative to China’s battery materials monopoly.
Q3 FY26 (September 2025 quarter) exposed the timing risk: while battery materials commercialization gains traction, core refrigerant revenues collapsed 33% YoY due to U.S. tariff whiplash and seasonal weakness. The stock has tanked -13% over 12 months, yet the company has never been better positioned. Or it’s just expensive, capital-heavy hope. Let’s find out.
Vivek Jain Moment: Devendra Kumar Jain, founder-chairman and promoter, passed away on December 29, 2025. His son Vivek Jain was appointed Chairman & MD on Feb 12, 2026. Succession risk in a multi-billion-capex play? That’s a footnote no one mentions in earnings calls.
03 — Business Model: Chemicals + EV Batteries = ???
They Sell Everything. Except Clarity.
GFL operates across five distinct verticals. The old core: fluoropolymers (PTFE, PFA, FEP, FKM, PVDF additives), fluorospecialties (pharma and agro intermediates), refrigerants (R-22, R-32, R-407C, R-410A), and bulk chemicals (caustic soda, chloroform, methylene dichloride). FY25 revenue split: ~54% from fluoropolymers, ~27% fluorochemicals, ~20% bulk chemicals. Geographically, 60% export revenue (U.S. 26%, Europe 21%, rest of world 12%). Standard specialty chemicals: high fixed costs, customer concentration risk, FX sensitivity.
The new pivot: Battery materials. In March 2024, GFL EV (100% subsidiary) commissioned India’s first integrated battery materials facility in Ranjitnagar. Products now live or in late qualification:
LiPF6 (Electrolyte Salt): Commercial supplies started December 2025. Approved by OEMs globally. Formula-linked pricing (tied to lithium carbonate). Repeat orders in Q4.
PVDF Binder: In final qualification stage. Commercial trials in vehicles. Revenue expected 2H FY27.
LFP Cathode Active Material (CAM): Plant stabilized. Samples dispatched. Approvals expected “over coming months.” Revenue likely 2H FY27 or later.
Oman Greenfield: $216 million capex (~₹1,800 crore), FTA advantages with U.S. and India, targeting commissioning by end-2027. This is where scale happens. This is also where GFL runs out of cash without dilution.
💬 Quick thought: IFC + sovereign funds invested ₹430 crore + $82 million in GFCL EV. Are they seeing a moonshot, or did they buy a seat at a Chinese supply-chain shuffle?
04 — Financials Overview
Q3 FY26: The Numbers That Shocked Everyone
Result type: Quarterly Results | Q3 FY26 Consolidated EPS: ₹9.29 | Annualised EPS (Q3×4): ₹37.16 | TTM EPS: ₹59.72
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 1,136 | 1,148 | 1,210 | -1.05% | -6.1% |
| Operating Profit | 275 | 294 | 364 | -6.5% | -24.5% |
| OPM % | 24% | 26% | 30% | -200 bps | -600 bps |
| PAT | 102 | 126 | 179 | -19.0% | -43.0% |
| EPS (₹) | 9.29 | 11.47 | 16.29 | -19.0% | -43.0% |
Translation: Q3 was a disaster-lite. Revenue flat, margins crushed, PAT down 19% YoY. Management blamed “the most challenging quarter” on (1) refrigerant seasonality + quota constraints (R-22), (2) delayed R-32 ramp (safety audits), (3) U.S. tariff uncertainty hitting volumes and pricing. But the real story is that core specialty chemicals is under compression, and the market is betting the farm on battery materials offsetting the pain starting FY27.
05 — Valuation: Fair Value Range
Is ₹3,152 Priced for Perfection or Delusion?
Join 10,000+ investors who read this every week.
